Two novel mutations in the human coagulation factor VII promoter

Anita Kavlie; Leena Hiltunen; Vesa Rasi; Hans Prydz

doi:10.1160/TH02-09-0050

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2003; 90(02): 194-205
DOI: 10.1160/TH02-09-0050

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Two novel mutations in the human coagulation factor VII promoter

Authors

Anita Kavlie
Leena Hiltunen

¹Finnish Red Cross Transfusion Service, Department of Haemostasis, Helsinki, Finland
Vesa Rasi

¹Finnish Red Cross Transfusion Service, Department of Haemostasis, Helsinki, Finland
Hans Prydz

Abstract

Summary

The factor VII genes of five unrelated Finnish female patients, F1-F5, with moderate bleeding tendency, were screened for mutations using single strand conformational polymorphisms and DNA sequencing. Heterozygous shifts were detected in exons 5 and 8 for patient F1, and sequencing confirmed the presence of the silent dimorphism H115H, the polymorphism R353Q and the mutation A294V. The patient F1 was also heterozygous for a novel –59T/G transversion mutation in the Hepatocyte nuclear factor 4-binding site. The remaining four patients carried a –32A/C transversion mutation located in a footprint (–51 to –32) covering the major transcription initiation start site (–51). There was also a consensus sequence match to an initiator response-like binding element covering –51. Two patients were homozygous and two heterozygous for this mutation. Plasma FVII:Ag and FVII:C levels were reduced in parallel. A strong reduction in binding affinity of a specific nuclear protein to the –32C-containing oligonucleotide was found by electrophoretic mobility shift assays on nuclear extracts from HepG2 cells. EDTA caused no reduced binding. A minimal promoter (–191 to +15) containing the wild-type sequence or the –32A/C or –59T/G mutations was cloned in front of the firefly luciferase reporter gene and transiently transfected into Hep3B cells. Reduced activities [23.0 ± 3.1% (–32C), 55.4 ± 6.3% (–59G), 100% (wild-type construct)] were found for the mutated promoters. Southwestern blotting and UV crosslinking analysis showed binding of three proteins (20, 20 and 50 kDa) to the putative initiator response element. The –32A/C mutant oligonucleotide bound two proteins.

Keywords

HNF4 - Initiator response element - mutations

Full Text

References

References
1 O’Hara PJ, Grant FJ, Haldeman BA. et al. Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A 1987; 84: 5158-62.
2 Erdmann D, Heim J. Orphan nuclear receptor HNF-4 binds to the human coagulation factor VII promoter. J Biol Chem 1995; 270: 22988-96.
3 Pollak ES, Hung HL, Godin W, Overton GC, High KA. Functional characterization of the human factor VII 5’-flanking region. J Biol Chem 1996; 271: 1738-47.
4 Greenberg D, Miao CH, Ho WT, Chung DW, Davie EW. Liver-specific expression of the human factor VII gene. Proc Natl Acad Sci USA 1995; 92: 12347-51.
5 Di Bitondo R, Hall AJ, Peake IR, Iacoviello L, Winship PR. Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region. Hum Mol Genet 2002; 11: 723-31.
6 Scarabin PY, Bonithon-Kopp C, Bara L, Malmejac A, Guize L, Samama M. Factor VII activation and menopausal status. Thromb Res 1990; 57: 227-34.
7 Arbini AA, Pollak ES, Bayleran JK, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter. Blood 1997; 89: 176-82.
8 Carew JA, Pollak ES, Lopaciuk S, Bauer KA. A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency. Blood 2000; 96: 4370-2.
9 Tidd T, Kudaravalli R, Beaverson K, Dimichele D, High K, Pollak E. Two novel mutations identified in the human coagulant protein factor VII gene. Thromb Haemost Suppl 1999; 467 Abstract 1476.
10 Carew JA, Pollak ES, High KA, Bauer KA. Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter. Blood 1998; 92: 1639-45.
11 Marchetti G, Patracchini P, Papacchini M, Ferrati M, Bernardi F. A polymorphism in the 5’ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet 1993; 90: 575-6.
12 Dell’Acqua G, Iacoviello L, D’Orazio A, Di Bitondo R, Di Castelnuovo A, Donati MB. A polymorphic cluster in the 5’ region of the human coagulation factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res 1997; 88: 445-8.
13 van’t Hooft F, Silveira A, Tornvall P. et al. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration. Blood 1999; 93: 3432-41.
14 Nederhand R, de Maat M, Koopman J, Kluft C. Linkage disequilibrium between Factor VII polymorphisms. Thromb Haemost Suppl 1999; 468 Abstract 1480.
15 Kavlie A, Orning L, Grindflek A, Stormorken H, Prydz H. Characterization of a factor VII molecule carrying a mutation in the second epidermal growth factor-like domain. Thromb Haemost 1998; 79: 1136-43.
16 Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 874-9.
17 Andrews NC, Faller DV. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 1991; 19: 2499
18 Gulowsen AC, Myrseth LE, Brandtzaeg P, Prydz H. A monoclonal antibody to a mega-karyoblast-like cell line detects a protein found in blood cells and in the epithelial cell lining of various rat tissues. Eur J Cell Biol 1990; 52: 142-6.
19 Carthew RW, Chodosh LA, Sharp PA. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell 1985; 43: 439-48.
20 Nguyen VT, Morange M, Bensaude O. Firefly luciferase luminescence assays using scintillation counters for quantitation in transfected mammalian cells. Anal Biochem 1988; 171: 404-8.
21 Pan T, Coleman JE. Structure and function of the Zn(II) binding site within the DNA- binding domain of the GAL4 transcription factor. Proc Natl Acad Sci USA 1989; 86: 3145-9.
22 Reseland JE, Larsen F, Solheim J, Eriksen JA, Hanssen LE, Prydz H. A novel human chymo-trypsin-like digestive enzyme. J Biol Chem 1997; 272: 8099-104.
23 Sladek FM, Zhong WM, Lai E, Darnell Jr. JE. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990; 4: 2353-65.
24 Reitsma PH, Bertina RM, Ploos vAJ, Riemens A, Briet E. The putative factor IX gene promoter in hemophilia B Leyden. Blood 1988; 72: 1074-6.
25 Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci U S A 1992; 89: 6300-3.
26 Toso R, Pinotti M, High KA, Pollak ES, Bernardi F. A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates. Biochem J 2002; 363: 411-6.
27 Wulff K, Schroder W, Wehnert M, Herrmann FH. Twenty-five novel mutations of the factor IX gene in haemophilia B. Hum Mutat 1995; 6: 346-8.
28 Arbini AA, Bodkin D, Lopaciuk S, Bauer KA. Molecular analysis of Polish patients with factor VII deficiency. Blood 1994; 84: 2214-20.
29 Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
30 Stauffer DR, Chukwumezie BN, Wilberding JA, Rosen ED, Castellino FJ. Characterization of transcriptional regulatory elements in the promoter region of the murine blood coagulation factor VII gene. J Biol Chem 1998; 273: 2277-87.
31 Javahery R, Khachi A, Lo K, Zenzie-Gregory B, Smale ST. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol Cell Biol 1994; 14: 116-27.
32 Smale ST, Baltimore D. The “initiator” as a transcription control element. Cell 1989; 57: 103-13.
33 Lo K, Smale ST. Generality of a functional initiator consensus sequence. Gene 1996; 182: 13-22.
34 Burke TW, Kadonaga JT. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev 1997; 11: 3020-31.
35 Shain DH, Neuman T, Zuber MX. A novel initiator regulates expression of the nontissue-specific helix- loop-helix gene ME1. Nucleic Acids Res 1995; 23: 1696-703.
36 Miyamoto M, Fujita T, Kimura Y. et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements. Cell 1988; 54: 903-13.
37 Pastier D, Lacorte JM, Chambaz J, Cardot P, Ribeiro A. Two initiator-like elements are required for the combined activation of the human apolipoprotein C-III promoter by USF and HNF-4. J Biol Chem 2002; 277: 15199-206.
38 Roy AL, Meisterernst M, Pognonec P, Roeder RG. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 1991; 354: 245-8.
39 Du H, Roy AL, Roeder RG. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J 1993; 12: 501-11.
40 Safer B, Reinberg D, Jacob WF. et al. Interaction of CAP sequence site binding factor and transcription factor IID preceding and following binding to the adenovirus 2 major late promoter. J Biol Chem 1991; 266: 10989-94.
41 Garfinkel S, Thompson JA, Jacob WF, Cohen R, Safer B. Identification and characterization of an adenovirus 2 major late promoter CAP sequence DNA-binding protein. J Biol Chem 1990; 265: 10309-19.
42 Roy AL, Du H, Gregor PD, Novina CD, Martinez E, Roeder RG. Cloning of an inr-and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J 1997; 16: 7091-104.
43 Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991; 67: 377-88.
44 Riggs KJ, Saleque S, Wong KK. et al. Yin-yang 1 activates the c-myc promoter. Mol Cell Biol 1993; 13: 7487-95.
45 Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipo-protein A-II gene. J Biol Chem 1999; 274: 1216-25.
46 Hough PV, Mastrangelo IA, Wall JS, Hainfeld JF, Sawadogo M, Roeder RG. The gene-specific initiation factor USF (upstream stimulatory factor) bound at the adenovirus type 2 major late promoter: mass and three- dimensional structure. Proc Natl Acad Sci U S A 1987; 84: 4826-30.
47 Weis L, Reinberg D. Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes. FASEB J 1992; 6: 3300-9.
48 Millar DS, Kemball-Cook G, McVey JH. et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000; 107: 327-42.